BioT: Decentralized Biotechnology Funding

What is BioT?

BioT is an ERC-20 token on Ethereum, designed to revolutionize biotechnology funding. Using audited smart contracts, BioT enables direct, transparent contributions to research, startups, and healthcare projects worldwide. With 485,000,000 tokens (10,000,000 circulating), BioT is live on Uniswap V2, fostering a community-driven ecosystem.

Tokenomics & Technical Details

• Contract Address: 0x7bC82B0775Bd344b1aC048b258b2d371Db5727a5
• Uniswap V2 Pool: 0x07D322eFA22207F77aA0b8C6aEBf2A87035e0EE0 (1.4M tokens)
• Total Supply: 485,000,000 tokens
• Circulating Supply: 10,000,000 tokens
• Allocation: 50% public sale, 30% development (locked until June 2027), 15% team (vested until June 2028), 5% marketing/partnerships
• Security: Audited and verified on Etherscan
• Fees: 1% on funding transactions for platform maintenance

BioT Whitepaper

Learn about BioT’s vision, technology, and roadmap.

Our Roadmap

• Q2 2025: Launched on Uniswap V2 (1.4M tokens), audited contract.
• Q3-Q4 2025: CoinGecko/CoinMarketCap listings, website launch, $2,000 airdrop (1M tokens), CEX listings (e.g., DigiFinex), biotech pilots.
• Q1-Q2 2026: Staking contract, Layer-2 integration, follow-up audit, pilot funding.
• Q3 2026: APIs for biotech platforms, more CEXs.

Get in Touch

For partnerships or inquiries, contact us at ganda314@yahoo.com.